Skip to content

Gilead Sciences GILD U.S. — Property, plant and equipment, net

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$166.77B+15.4%
Enterprise value$181.31B+10.3%
P/E18.1×-4.8×
P/S5.6×+0.6×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Gilead Sciences’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's u.s. — property, plant and equipment, net.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's U.S. — property, plant and equipment, net?
Gilead Sciences (GILD) reported U.S. — property, plant and equipment, net of $4.98B in Q4 2025.
How has Gilead Sciences's U.S. — property, plant and equipment, net changed year-over-year?
Gilead Sciences's U.S. — property, plant and equipment, net increased by 3.9% year-over-year, from $4.79B to $4.98B.